Document is current
Any future updates will be listed below
-
Authors
Triemstra, Lianne https://orcid.org/0000-0002-7057-0274
Spruijt, Sarah W. J. M. https://orcid.org/0009-0001-6902-2182
Vriens, Dennis https://orcid.org/0000-0001-5762-6766
Vegt, Erik https://orcid.org/0000-0001-7456-2258
Mesker, Wilma E. https://orcid.org/0000-0001-5533-4778
Hawinkels, Lukas J. A. C. https://orcid.org/0000-0002-2274-9325
Saing, Sopany https://orcid.org/0000-0001-5913-9654
Slingerland, Marije https://orcid.org/0000-0002-4181-8656
Kemp, Vera https://orcid.org/0000-0003-4910-4655
Crobach, Stijn A. L. P. https://orcid.org/0000-0002-1289-4406
Goeman, Jelle J. https://orcid.org/0000-0003-4283-0259
Pool, Martin https://orcid.org/0000-0002-4892-3109
Dibbets-Schneider, Petra https://orcid.org/0000-0003-0538-8270
Bennink, Roel J. https://orcid.org/0000-0003-1196-1416
van Berge Henegouwen, Mark I. https://orcid.org/0000-0001-8689-3134
van Det, Marc J. https://orcid.org/0000-0002-7338-2818
van Etten, Boudewijn J. https://orcid.org/0000-0003-2900-2942
Hartgrink, Henk H. https://orcid.org/0000-0003-0015-8556
van Hillegersberg, Richard https://orcid.org/0000-0002-7134-261X
Lam, Marnix G. E. H. https://orcid.org/0000-0002-4902-9790
Smulders, Nanda M.
Luyer, Misha D. P. https://orcid.org/0000-0002-9483-1520
Noordzij, Walter https://orcid.org/0000-0001-6386-5499
Owers, Emilia C. https://orcid.org/0009-0008-5242-2340
Oyen, Wim J. G. https://orcid.org/0000-0001-8235-7078
van Sandick, Johanna W. https://orcid.org/0000-0002-1208-6388
Schreurs, Wendy
de Steur, Wobbe O. https://orcid.org/0000-0002-8095-7798
Stoot, Jan H. M. B. https://orcid.org/0000-0003-3178-0049
Weijs, Leo E.
Wijnhoven, Bas P. L. https://orcid.org/0000-0003-4738-3697
Witteman, Bart P. L.
Ruurda, Jelle P. https://orcid.org/0000-0001-6584-1677
de Geus-Oei, Lioe-Fee https://orcid.org/0000-0003-1817-2743
,
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (15400)
- License Information
-
More Information
Article History
Received: 9 October 2025
Accepted: 13 November 2025
First Online: 27 November 2025
Declarations
:
: The study was approved by the Medical Research Ethics Committee (MREC, Dutch: METC) Leiden-The Hague-Delft (reference number: P25.012) on May 5th 2025. As this study does allocate patients to study interventions other than usual care, as recommended by the Dutch guidelines, this study does fall within the Medical Research Involving Human Subjects Act (WMO). Written informed consent will be obtained from all study participants.
: Not applicable.
: MIBH is consultant for Intuitive, Johnson and Johnson, Medtronic, Stryker and BBraun (all fees paid to institution). LJACH received consultant fees and is member scientific advisory board of InnoSer Biosciences (not related). MGEHL is consultant and research support for Terumo, Boston Scientific, consultant for OncoSil, Becton and Dickinson and Novartis. MDPL received grants from Medtronic and Galvani for research. All other authors declare they have no competing interests.
